A.I. Learns to Write in DNA
Scientists prompted A.I. to design and create new viruses for the first time, a milestone for medicine that also raises new biosecurity concerns.
Yahoo Finance reports that Moonshot AI, a Chinese startup, is preparing a Hong Kong IPO that would value the company at $50 billion — driven by the launch of its new Kimi K3 model, which early benchmarks suggest competes with leading Western AI offerings. The $50 billion figure would place Moonshot at roughly the valuation Anthropic commanded last year, a remarkable position for a company that was barely known outside China six months ago.
Kimi K3 is the engine behind the IPO ambitions. Whether the model's benchmark performance holds up to independent scrutiny beyond early evaluations remains to be seen, but investor appetite appears real.
The broader story here is about fragmentation. As geopolitical tensions limit cross-border AI collaboration, regional champions are consolidating — companies that might once have operated in a global talent and capital market are now building national-scale AI ecosystems. Moonshot AI appears to be China's answer to the Western frontier labs.
A $50 billion valuation for a company this new would make Moonshot one of the fastest AI startup ascents on record — if the IPO lands as planned.
All comments are reviewed before appearing. Keep it respectful.
Scientists prompted A.I. to design and create new viruses for the first time, a milestone for medicine that also raises new biosecurity concerns.
The Trump administration has no idea on how to handle open-source and open-weight AI models from China.
Google is consolidating AI leadership in California but the reorganization is pushing out the engineers who built its AI division